Bravado Pharmaceuticals

Bravado Pharmaceuticals is a pharmaceutical development company that takes drug products from research and development through early phase clinical manufacturing. Its work covers formulation development, analytical testing and manufacturing, with dosage forms ranging from oral solids to injectables. The company also runs a 503B outsourcing facility for sterile and non-sterile compounding. Founder Brian McMillan has spent decades on tablet systems and combination products, and the company has worked with Stanford University on CoVer Nasal Antibody Drops.

Bravado designs each development program around the client's needs rather than a fixed process, and it emphasizes short timelines. The team is based in Lutz, and it works mainly with pharmaceutical clients, so most business is handled by proposal request, phone or email. Existing clients can use a client login on the website.